GAMBARAN KUALITAS HIDUP HOLISTIK PASIEN KANKER PAYUDARA YANG MENJALANI KEMOTERAPI DI SATU RUMAH SAKIT SWASTA DI INDONESIA [DESCRIPTION OF HOLISTIC QUALITY OF LIFE OF BREAST CANCER PATIENTS THROUGH CHEMOTHERAPY IN A PRIVATE HOSPITAL IN INDONESIA]
DOI:
https://doi.org/10.19166/nc.v8i2.3104Trefwoorden:
Breast Cancer, Chemotherapy, Quality Of LifeSamenvatting
Breast cancer is one of the leading causes of death among women. Worldwide data Cancer Observatory 2018 from the World Health Organization (WHO) shows the most common cases in Asia is breast cancer, which is 58,256 cases or 16,7 of the 348,809 cancer cases. Kemenkes, 2019 said that the number of breast cancer cases have reached 17 people of 100 thousand of population. One of the treatments is chemotherapy. But chemotherapy can affect quality of life of a patient includes physical, psychological and spiritual aspects. The research aims to identify the quality of life of the breast cancer patient who undergo chemotherapy in descriptive qualitative design. Research data has been analyzed with a thematical analyzed. Research has been approved through Mochtar Riady Institute for Nanotechnology (MRIN). The result of research have found five themes that reflect the quality of holistic life of breast cancer patient, whic is 1) Physical disorder; 2) Psychological Aspect; 3) Hope; 4) Acceptance; 5) Support System. The number of samples were examined four people. Research was conducted on 6 September until 11 September 2016 in a Private Hospital In West Indonesia. Recommendations to researchers further the use of the number of participants in order to gain more in-depth experience from various participants.
BAHASA INDONESIA Kanker payudara merupakan salah satu penyebab kematian utama di kalangan perempuan. Data Global Cancer Observatory 2018 dari World Health Organization (WHO) menunjukkan kasus kanker yang paling banyak terjadi di Asia adalah kanker payudara, yakni 58.256 kasus atau 16,7 dari total 348.809 kasus kanker. Kemenkes, 2019 menyatakan angka kanker payudara di Indonesia telah mencapai 17 orang per 100 ribu penduduk. Salah satu pengobatan yang dapat dilakukan adalah kemoterapi. Kemoterapi dapat berpengaruh pada kualitas hidup pasien yang meliputi aspek fisik, psikologis, psikososial dan spiritual. Penelitian ini bertujuan untuk mengidentifikasi kualitas hidup pasien kanker payudara yang menjalani pengobatan kemoterapi dengan menggunakan desain deskriptif kualitatif. Data penelitian telah dianalisis dengan pendekatan tematikal. Penelitian telah melalui kaji etik/ ethical approval dari Mochtar Riady Institude for Nanotechnology (MRIN). Hasil penelitian mendapatkan terdapat lima tema yang menjadi gambaran kualitas hidup holistik pasien kanker payudara, yaitu 1) Gangguan fisik; 2) Ketidaknyamanan psikologis; 3) Harapan; 4) Acceptance; dan 5) Support system. Jumlah sampel yang diteliti adalah sebanyak empat orang. Penelitian telah dilakukan pada tanggal 06 September sampai 11 September 2016 di Satu Rumah Sakit Swasta Di Indonesia. Rekomendasi kepada peneliti selanjutnya penggunaan jumlah partisipan lebih dari empat orang agar mendapatkan pengalaman yang lebih mendalam dari berbagai pasrtisipan.
Referenties
Avryna, P., Wahid, I., & Fauzar, F. (2019). Invasive Carcinoma Mammae dengan Metastasis Orbita, Tulang, dan Paru. Jurnal Kesehatan Andalas, 8(1S), 89-93. https://doi.org/10.25077/jka.v8i1S.932
Black, J. M., & Hawks J. H. (2014). Keperawatan Medikal Bedah Buku 3. (8th ed.). Singapore: Elsevier.
Endarti, A. T. (2015). Kualitas Hidup Kesehatan: Konsep, Model, dan Penggunaan. Jurnal Ilmiah Kesehatan, 7(2), 1-12. http://lp3m.thamrin.ac.id/upload/jurnal/JURNAL-1519375940.pdf
Faisel, C., Heriady, Y., & Fitriangga, A. (2012). Gambaran Efek Samping Kemoterapi Berbasis Antrasiklin Pada Pasien Kanker Payudara Di RSUD Dokter Soedarso Pontianak. https://jurnal.untan.ac.id/index.php/jfk/article/viewFile/1769/1713
Handayani, L., Medi, M., & Ayuningtya, A. (2012) . Menaklukkan Kanker Serviks Dan Kanker Payudara Dengan 3 Terapi Alami. Jakarta: PT. AgroMedia Pustaka.
Ismail, N., & Sri, H. (2019). Metodiologi Penelitian Sosial. Surabaya: MSC.
Kemenkes Republik Indonesia. (2019). Kasus Kanker Payudara Paling Banyak Terjadi di Indonesia.
Prastiwi, T. F. (2012). Kualias Hidup Pasien Penderita Kanker. Developmental and Clinical Psychology, 1(1), 21-27. https://journal.unnes.ac.id/sju/index.php/dcp/article/view/2630
Rochmawati, D. (2015). Kualitas Hidup Pasien Ca Mammae Yang Menjalani Kemoterapi Di RSUD Dr. Moewardi. SKRIPSI. Program Studi S-1 Keperawatan STIKES Kusuma Husada, Surakarta. https://adoc.pub/kualitas-hidup-pasien-ca-mammae-yang-menjalani-kemoterapi-di.html
Sari, S. E., Harahap, W. A., & Saputra, D. (2018). Pengaruh Faktor Risiko Terhadap Ekspresi Reseptor Estrogen Pada Penderita Kanker Payudara Di Kota Padang. Jurnal Kesehatan Andalas, 7(4), 461. https://doi.org/10.25077/jka.v7i4.902
World Health Organization. (2020). Breast cancer. Retrieved from https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
Yabro H., Wujcik D., Gobel H. (2011). Cancer Nursing. Boston, MA:Jones and Bartlett.
##submission.downloads##
Gepubliceerd
Citeerhulp
Nummer
Sectie
Licentie
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
